[ad_1] PARAMUS, N.J., Aug. 20, 2024 /PRNewswire/ — Octapharma USA has received U.S. Food and Drug Administration Emergency Use Authorization (EUA) for its proprietary octaplasLG Powder (blood group types A and AB). The EUA allows […]
[ad_1] PARAMUS, N.J., Aug. 20, 2024 /PRNewswire/ — Octapharma USA has received U.S. Food and Drug Administration Emergency Use Authorization (EUA) for its proprietary octaplasLG Powder (blood group types A and AB). The EUA allows […]